KRAS and neoplasm: KRAS expression was positively correlated with several clinical and pathological indicators of the tumor progression, including the histological grade, the tumor extent, the nodal status, and the pathological stage (r=0.712, 0.649, 0.646, and 0.865, respectively; Table 3).